Compare · 2 funds side by side · dividends reinvested

CURE and VTI

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$16,332VTI · best of the two

02 / 04

CURE and VTI, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard Morningstar Total Stock Market ETFLow-Cost Core · Total US market0.03%1.10%+8.4%+9.9%+21.9%+10.3%−8.9%13.7%$689B1.4

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+50.8%+81.4%+29.9%+7.9%−31.1%49.4%$217M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: CURE 2011 · VTI 2001

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $217M$14,647

CURE

VTI

Vanguard Morningstar Total Stock Market ETF · $689B$16,332

$10,000 five years ago, dividends reinvested · they hold 8.4% in common

CUREMeasureVTI

+50.8%Year to dateJan 1 → Nov 5+8.4%

+81.4%1 yearTotal return+9.9%

+29.9%3 years · per year$10,000 became $21,930 · $18,113+21.9%

+7.9%5 years · per year$10,000 became $14,647 · $16,332+10.3%

0.94%Expense ratio$94 · $3 a year on $10k · lower is better0.03%

0.76%Trailing 12-mo yield$76 · $110 a year on $10k1.10%

−31.1%Worst dropSmaller is better−8.9%

49.4%VolatilityLower is calmer13.7%

CUREVTI Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5VTI wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs VTI: Top 5 Holdings

Today

CURE

8.9%in top 5

VTI

in top 525.0%

CUREStockVTI

not top 5NVDA7.1%

not top 5AAPL6.6%

not top 5MSFT5.2%

not top 5AMZN3.3%

3.3%LLYnot top 5

not top 5GOOGL2.8%

1.9%JNJnot top 5

1.5%ABBVnot top 5

1.1%MRKnot top 5

1.1%UNHnot top 5

Held in common8.4%

End-of-day Nov 5, 2026 · share of each fund

CURE vs VTI Returns, Every Period

DirexionCURE

+7.9%

5 years, per year

VTIVanguard

+10.3%

5 years, per year

CUREVTIFaded: behind in that period

3–1CURE wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

Leveraged vs Core: CURE vs VTI

YTD

DirexionCURE

+50.8%

VTIVanguard

+8.4%

+50.8%Year to date+8.4%

−31.1%Worst drop · 1Y−8.9%

49.4%Volatility · 1Y13.7%

0.8%Yield1.1%

$217MAssets$689B

3–1VTI wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, VTI

Today

0.03%lowest, VTI

FundExpense ratioFee$10k

VTI0.03%$3

CURE0.94%$94

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: CURE, VTI

1.10%highest, VTI

FundTrailing yieldYield$10k

VTI1.10%$110

CURE0.76%$76

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$107most kept, VTI

VTI$110 − $3 = $107

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: CURE, VTI

Today

8.4%most shared, CURE and VTI

CUREVTI

CURE—8.4%

VTI8.4%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+81.4%CURE, at 49.4% volatility

VTIWorst drop−8.9%13.7% vol

CUREWorst drop−31.1%49.4% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

VTICURE

+8.4%Year to date+50.8%

1.1%Yield0.8%

+9.9%Past year+81.4%

0.03%Fee0.94%

2–2level

End-of-day Nov 5, 2026

Popular Pairs Near These Two

VTI vs ITOT

YTD

VanguardVTI

+8.4%

ITOTiShares

+8.4%

+8.4%Year to date+8.4%

1.1%Yield1.1%

$689BAssets$92.8B

0–0level

End-of-day Nov 5, 2026

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.6BAssets$46.8B

2–0JEPQ wins

End-of-day Nov 5, 2026